Kyverna Therapeutics | 10-Q: Quarterly report
Kyverna Therapeutics | 8-K: Kyverna Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
Kyverna Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Vida Ventures, LLC(11.1%),VV Manager LLC(11.1%), etc.
Kyverna Therapeutics | 10-K: Annual report
Kyverna Therapeutics | 8-K: Current report
Kyverna Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Michael P. Rubin(7.6%),Northpond Ventures III, LP(6.5%), etc.
Kyverna Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Gilead Sciences, Inc.(9 . 6%)
Kyverna Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Vida Ventures, LLC
Kyverna Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Cohen Fred E
Kyverna Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SEIDENBERG BETH C
Kyverna Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Westlake BioPartners Fund I, L.P.
Kyverna Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Bain Capital Life Sciences Investors, LLC
Kyverna Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Bain Capital Life Sciences Opportunities III, LP(7.4%)
Kyverna Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner GILEAD SCIENCES, INC.
Kyverna Therapeutics | SEC STAFF LETTER: Others
Kyverna Therapeutics | 4: Statement of changes in beneficial ownership of securities- Northpond Ventures III GP, LLC
Kyverna Therapeutics | 8-K: Current report
Kyverna Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Kyverna Therapeutics | 424B4: Prospectus
Kyverna Therapeutics | CERT: Others
No Data